- Autori:
-
Carbone, C.; Melisi, Davide
- Titolo:
-
NF-κB as a target for pancreatic cancer therapy.
- Anno:
-
2012
- Tipologia prodotto:
-
Articolo in Rivista
- Tipologia ANVUR:
- Articolo su rivista
- Lingua:
-
Inglese
- Referee:
-
No
- Nome rivista:
- EXPERT OPINION ON THERAPEUTIC TARGETS
- ISSN Rivista:
- 1472-8222
- Intervallo pagine:
-
1-10
- Parole chiave:
-
NFkB; TAK1
- Breve descrizione dei contenuti:
- Introduction: Pancreatic cancer is the fourth leading cause of adult cancer mortality in the USA. It represents one of the greatest challenges in cancer treatment. The NF-κB transcriptional factors are constitutively activated in the majority of pancreatic cancers and are involved in the regulation of numerous aspects of tumor development and progression. NF-κB and the signaling cascades that regulate its activity have thus become attractive targets for novel therapeutic approaches for pancreatic cancer. Areas covered: This review describes and discusses the most important advances in the comprehension of the complex molecular biology of NF-κB, as well as the development of novel NF-κB-targeting strategies for the treatment of pancreatic cancer. Expert opinion: Although the inhibition of NF-κB, especially when combined with more classic chemotherapeutic drugs, could be a promising therapeutic strategy, direct targeting NF-κB still faces important challenges. In the future, targeting nonredundant cytosolic mediators of the activation of NF-κB - such as TNF receptor associated factor family member-associated NF-κB activator -binding kinase 1 (TBK1) and TGF-beta activated kinase 1 (TAK1) - could represent a better approach to inhibit key processes in pancreatic tumor cells and make a difference for this devastating disease.
- Pagina Web:
-
http://dx.doi.org/10.1517/14728222.2011.645806
- Id prodotto:
-
66728
- Handle IRIS:
-
11562/393944
- depositato il:
-
27 marzo 2012
- ultima modifica:
-
15 novembre 2022
- Citazione bibliografica:
-
Carbone, C.; Melisi, Davide,
NF-κB as a target for pancreatic cancer therapy.
«EXPERT OPINION ON THERAPEUTIC TARGETS»
,
2012
,
pp. 1-10
Consulta la scheda completa presente nel
repository istituzionale della Ricerca di Ateneo 
